SCHEMBL228843

SCHEMBL228843

[NH]CCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL359767 0.75
SCHEMBL887981 0.72
SCHEMBL947607 0.71
Ethylenediamine SCHEMBL37647 0.63
Ethylenediamine SCHEMBL30253568 0.63
Ethylenediamine SCHEMBL28924405 0.63 NFKB1 (0.50)
Ethylenediamine SCHEMBL7085968 0.63 NFKB1 (0.50)
SCHEMBL190090 0.63
Ethylenediamine SCHEMBL3083 0.63
SCHEMBL424627 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2306 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024125179-A1 CHAOTROPES-ASSISTED DEEP IMMUNOSTAINING THE CHINESE UNIVERSITY OF HONG KONG (CN) 2024-06-20 WO claimed
US-20240199857-A1 CHAOTROPES-ASSISTED DEEP IMMUNOSTAINING THE CHINESE UNIVERSITY OF HONG KONG (CN) 2024-06-20 US claimed
CN-118178668-A Application of fullerene derivative in iron death resistance 北京福纳康生物技术有限公司 2024-06-14 CN claimed
CN-118076594-A Sulfonylpiperazinyl compounds for the treatment of bacterial infections 豪夫迈·罗氏有限公司 2024-05-24 CN claimed
US-11987588-B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2024-05-21 US claimed
WO-2024097346-A1 PROCESS FOR PRODUCING FUNCTIONALIZED POROUS COMPOSITES CELANESE INTERNATIONAL CORPORATION (US) 2024-05-10 WO claimed
WO-2024097348-A2 PROCESS AND DEVICE FOR REMOVING CONTAMINANTS FROM A FLUID STREAM CELANESE INTERNATIONAL CORPORATION (US) 2024-05-10 WO claimed
WO-2024097342-A1 FUNCTIONALIZED POROUS COMPOSITES CELANESE INTERNATIONAL CORPORATION (US) 2024-05-10 WO claimed
WO-2024097343-A1 FUNCTIONALIZED POROUS COMPOSITES CONTAINING CHEMICAL SCAVENGERS CELANESE INTERNATIONAL CORPORATION (US) 2024-05-10 WO claimed
US-20240150538-A1 Process for Producing Functionalized Porous Composites CELANESE INTERNATIONAL CORPORATION 2024-05-09 US claimed
EP-0164944-A1 Cephalosporin derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-12-18 EP claimed
EP-0164247-A1 Dihydropyridines Pfizer Limited (GB) 1985-12-11 EP claimed
EP-0046572-B1 6-QUINAZOLINESULFONYL DERIVATIVES AND PROCESS FOR PREPARATION THEREOF Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-10-31 EP claimed
EP-0114002-A2 Benzothiopyrano(4,3,2,-cd)indazoles, their pharmaceutical compositions and methods for their production WARNER-LAMBERT COMPANY (US) 1984-07-25 EP claimed
EP-0082023-A2 Thienopyrimidine derivatives, their preparation and their medical use SANKYO COMPANY LIMITED (JP) 1983-06-22 EP claimed
US-4336395-A PROCESS FOR PREPARING (AMINOMETHYL) PHENYL-ETHYLDIMETHYLMETHOXYSILANE PETRARCH SYSTEMS, INC. (US) 1982-06-22 US claimed
EP-0046572-A2 6-Quinazolinesulfonyl derivatives and process for preparation thereof Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-03-03 EP claimed
US-4257946-A Benzodiazepine intermediates for the preparation of imidazobenzodiazepines HOFFMANN-LA ROCHE INC. (US) 1981-03-24 US claimed
US-4210573-A Polyolefin containers having improved gas barrier properties THE CONTINENTAL GROUP INC. (US) 1980-07-01 US claimed
US-3932642-A BACTERICIDES, FUNGICIDES, TRICHOMONOCIDES BOEHRINGER INGELHEIM GMBH (DT) 1976-01-13 US claimed